Population
Patients with acute decompensated chronic heart failure (ADCHF)
Design
Review
Authors
Loading...
May support levosimendan consideration in acute HF; leaves open outcome effects pending RCTs.
Levosimendan represents a therapeutic option for acute decompensated heart failure by improving contractility without increasing oxygen demand.
Ferenc Folláth (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: